Cargando…
Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
Plant-based biomanufacturing of therapeutic proteins is a relatively new platform with a small number of commercial-scale facilities, but offers advantages of linear scalability, reduced upstream complexity, reduced time to market, and potentially lower capital and operating costs. In this study we...
Autores principales: | Nandi, Somen, Kwong, Aaron T., Holtz, Barry R., Erwin, Robert L., Marcel, Sylvain, McDonald, Karen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098453/ https://www.ncbi.nlm.nih.gov/pubmed/27559626 http://dx.doi.org/10.1080/19420862.2016.1227901 |
Ejemplares similares
-
Techno‐economic analysis of a plant‐based platform for manufacturing antimicrobial proteins for food safety
por: McNulty, Matthew J., et al.
Publicado: (2019) -
Process Simulation and Techno-Economic Analysis of Large-Scale Bioproduction of Sweet Protein Thaumatin II
por: Kelada, Kirolos D., et al.
Publicado: (2021) -
Techno-economic process modelling and Monte Carlo simulation data of uncertainty quantification in field-grown plant-based manufacturing
por: McNulty, Matthew J., et al.
Publicado: (2021) -
In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants
por: Kommineni, Vally, et al.
Publicado: (2019) -
Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
por: Sukenik, Sara C., et al.
Publicado: (2018)